Financial Results
First Quarter 2024 Financial Results
Genmab will present its financial results for the first quarter of 2024 on May 2, 2024.
First Quarter 2024 Financial Results
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
From Where We Started to Where We are Going
Our Products
We are focused on our vision of transforming the future of cancer treatment.
Investors
We aim to share relevant, accurate and timely information with our investors.
Genmab News
With innovations, partnerships and presentations, we are making headlines.
Our Science
Our passion for innovation is driven by data and rooted in science.
Current Partnerships
We know the value of finding and being good partners.
Our Medicines
We are committed to make an impact on the lives of people with cancer.
On the lookout for a life-changing career?
Join our team of extra[not]ordinary™ people and become part of a company working to pioneer antibody medicines for cancer and other serious diseases.